Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HERBALIFE LTD.HLF · Entity 4842 | Chief Operating Officer | February 26, 2021 | March 03, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HERBALIFE LTD.
Report date February 26, 2021 · Filed March 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 170,316 |
Reported balance
After 2021-02-26 transaction · row 1
1 source rowRow 1 · 2021-02-26 · Tax withholding · Disposed 2,069 · Balance 170,316 F1: Units withheld to satisfy tax withholding obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 26, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: Units withheld to satisfy tax withholding obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 26, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2021 Filed Mar 3, 2021 01:38 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 2,069 | $44.98 | $93,063.62 |
DisclosureSEC source: 0001209191-21-016567 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,316 F1 · shares: Units withheld to satisfy tax withholding obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 26, 2018. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 01:36 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 531 | $48.33 | $25,663.23 |
DisclosureSEC source: 0001209191-21-013529 · doc4.xml · nonDerivative · entry 3 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,385 F3 · shares: Units withheld to satisfy tax withholding obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 21, 2019. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 01:36 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 786 | $48.33 | $37,987.38 |
DisclosureSEC source: 0001209191-21-013529 · doc4.xml · nonDerivative · entry 2 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,916 F2 · shares: Units withheld to satisfy tax withholding obligations due in connection with the vesting of RSUs previously granted to the Reporting Person on February 20, 2020. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:36 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 7,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013529 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,702 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 19, 2022, 20% on February 19, 2023, and 60% on February 19, 2024, subject to continued service through each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 13,238 | $58.35 | $772,490.25 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 15 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,943 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: This transaction was executed in multiple trades at prices ranging from $58.0000 to $58.6250. The price reported reflects the weighted average sale price of $58.3540. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 15,801 | $57.61 | $910,357.23 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 14 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,181 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: This transaction was executed in multiple trades at prices ranging from $57.0900 to $57.9900. The price reported reflects the weighted average sale price of $57.6139. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 5,644 | $56.73 | $320,162.67 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 13 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,982 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $56.2100 to $56.9900. The price reported reflects the weighted average sale price of $56.7262. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 45,902 | $0.00 Strike: $28.60 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · derivative · entry 20 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,902 shares Expires 2027-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 22,951 shares at an exercise price of $57.19 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F15 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 22,951 shares at an exercise price of $57.19 per share. F16 · derivative.exercise_date: The SARS were granted on February 27, 2017. 20% vested on February 27, 2018, 20% vested on February 27, 2019 and the remaining 60% vested on February 27, 2020. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 43,668 | $0.00 Strike: $31.26 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · derivative · entry 19 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,668 shares Expires 2026-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 21,834 shares at an exercise price of $62.51 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F13 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 21,834 shares at an exercise price of $62.51 per share. F14 · derivative.exercise_date: The SARS were granted on May 9, 2016. 20% vested on May 9, 2017, 20% vested on May 9, 2018 and the remaining 60% vested on May 9, 2019. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 29,508 | $0.00 Strike: $39.79 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · derivative · entry 18 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,508 shares Expires 2023-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 14,754 shares at an exercise price of $79.58 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F11 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 14,754 shares at an exercise price of $79.58 per share. F12 · derivative.exercise_date: The SARS were granted on December 19, 2013. 20% vested on June 21, 2014, 20% vested on June 21, 2015 and the remaining 60% vested on June 21, 2016. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 6,816 | $0.00 Strike: $33.85 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · derivative · entry 17 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,816 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 3,408 shares at an exercise price of $67.70 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as covering 3,408 shares at an exercise price of $67.70 per share. F10 · derivative.exercise_date: The SARS were granted on March 1, 2012. 20% vested on March 1, 2013, 20% vested on March 1, 2014 and the remaining 60% vested on March 1, 2015. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 20,764 | $0.00 Strike: $26.65 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · derivative · entry 16 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,764 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 10,382 shares at an exercise price of $53.29 per share. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 10,382 shares at an exercise price of $53.29 per share. F8 · derivative.exercise_date: The SARS were granted on May 18, 2011. 20% vested on May 18, 2012, 20% vested on May 18, 2013 and the remaining 60% vested on May 18, 2014. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 17,672 | $55.83 | $986,627.76 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 12 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,626 F3 · shares: Units withheld to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 35,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 11 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,298 F2 · shares: Represents common shares earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2018-2020 performance period. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 34,614 | $55.83 | $1,932,499.62 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 10 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,656 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 45,902 | $28.60 | $1,312,567.69 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 9 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 33,978 | $55.83 | $1,896,991.74 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 8 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,368 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 43,668 | $31.26 | $1,364,843.34 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 7 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 24,579 | $55.83 | $1,372,245.57 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 6 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,678 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 29,508 | $39.79 | $1,174,123.32 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 5 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 5,061 | $55.83 | $282,555.63 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 4 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,749 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 6,816 | $33.85 | $230,721.60 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 3 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 13,743 | $55.83 | $767,271.69 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 2 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,994 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 20,764 | $26.65 | $553,256.78 |
DisclosureSEC source: 0001209191-21-009470 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 23:40 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 38,350 | $55.00 | $2,109,250.00 |
DisclosureSEC source: 0001209191-21-008960 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,973 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Balance reflects shares purchased through the Issuer's Herbalife Ltd. Employee Stock Purchase Plan since last reported on Form 4. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:56 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 481 | $33.27 | $16,002.87 |
DisclosureSEC source: 0001209191-20-013961 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,794 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 26, 2018. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 22:05 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 27,542 | $0.00 Strike: $28.60 | $0.00 |
DisclosureSEC source: 0001209191-20-012048 · doc4.xml · derivative · entry 3 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,902 Underlying: Common Stock · 27,542 shares Expires 2027-02-27 F3 · shares: On February 27, 2017, the Reporting Person was granted an award of 45,902 PSARs (number adjusted to reflect the Issuer's 2-for-1 stock split on May 14, 2018). The amount and timing of the vesting of these PSARs was dependent upon achievement by the Issuer of certain performance criteria for each of fiscal 2017, 2018 and 2019. With the satisfaction of the performance criteria for fiscal 2019, 27,542 PSARs will vest on February 27, 2020, subject to continued service through each applicable date. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 22:05 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 370 | $37.45 | $13,856.50 |
DisclosureSEC source: 0001209191-20-012048 · doc4.xml · nonDerivative · entry 2 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,275 F2 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 21, 2019. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:05 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 7,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012048 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,645 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 20, 2021, 20% on February 20, 2022, and 60% on February 20, 2023, subject to continued service through each applicable date. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:30 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 5,568 | $42.58 | $237,085.44 |
DisclosureSEC source: 0001209191-20-007667 · doc4.xml · nonDerivative · entry 2 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,719 F3 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of such PSUs. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 23:30 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 15,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007667 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,287 F1 · shares: Represents common stock earned by the Reporting Person in connection with the vesting of performance share units ("PSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan based on pre-established performance goals for a 2017-2019 performance period. F2 · balance_after: Balance reflects shares purchased through the Issuer's Herbalife Ltd. Employee Stock Purchase Plan since last reported on Form 4. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 23:15 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 519 | $56.52 | $29,333.88 |
DisclosureSEC source: 0001209191-19-014683 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,035 F1 · shares: Units withheld to satisfy the withholding tax obligations due in connection with the vesting of restricted stock units previously granted to the Reporting Person on February 26, 2018. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 22:39 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 9,180 | $0.00 Strike: $28.60 | $0.00 |
DisclosureSEC source: 0001209191-19-013121 · doc4.xml · derivative · entry 3 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,360 Underlying: Common Stock · 9,180 shares Expires 2027-02-27 F4 · shares: On February 27, 2017, the Reporting Person was granted an award of 45,902 PSARs, which number reflects the Issuer's 2-for-1 stock split on May 14, 2018. The amount and timing of the vesting of these PSARs is dependent upon achievement by the Issuer of certain performance criteria for each of fiscal 2017, 2018 and 2019. As the performance criteria for 2018 has been satisfied, 9,180 PSARs will vest on February 27, 2019, subject to continued service through each applicable date. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 22:39 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantStock Appreciation Rights · Derivative | 26,200 | $0.00 Strike: $31.26 | $0.00 |
DisclosureSEC source: 0001209191-19-013121 · doc4.xml · derivative · entry 2 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,668 Underlying: Common Stock · 26,200 shares Expires 2026-05-09 F3 · shares: On May 9, 2016, the Reporting Person was granted an award of 43,668 performance stock appreciation rights ("PSARs"), which number reflects the Issuer's 2-for-1 stock split on May 14, 2018. The amount and timing of the vesting of these PSARs is dependent upon achievement by the Issuer of certain performance criteria for each of fiscal 2016, 2017 and 2018. As the performance criteria for 2018 has been satisfied, 26,200 PSARs will vest on May 9, 2019, subject to continued service through each applicable date. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 22:39 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 5,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013121 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,554 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 20% on February 21, 2020, 20% on February 21, 2021, and 60% on February 21, 2022, subject to continued service through each applicable date. F2 · balance_after: Balance reflects shares purchased through the Issuer's Herbalife Ltd. Employee Stock Purchase Plan following a reconciliation to the Reporting Person's account records. Read SEC document |
| September 18, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 66,805 | $55.12 | $3,682,291.60 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 11 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,940 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F7 · price: This transaction was executed in multiple trades at prices ranging from $54.65 to $55.59. The price reported reflects the weighted average sale price of $55.12. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 106,034 | $0.00 Strike: $15.22 | $0.00 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · derivative · entry 14 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,034 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F6 · kind: The reporting person received 38,831 shares of common stock upon the net exercise of 106,034 SARS. The reporting person forfeited 29,016 shares of common stock underlying the SARS in payment of the exercise price and 38,187 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. F10 · derivative.underlying_shares: These SARS were previously reported as covering 53,017 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 37,528 | $0.00 Strike: $29.99 | $0.00 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · derivative · entry 13 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,528 shares Expires 2024-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F5 · kind: The reporting person received 8,719 shares of common stock upon the net exercise of 37,528 SARS. The reporting person forfeited 20,235 shares of common stock underlying the SARS in payment of the exercise price and 8,574 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. F9 · derivative.underlying_shares: These SARS were previously reported as covering 18,764 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 63,934 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · derivative · entry 12 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 63,934 shares Expires 2022-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F4 · kind: The reporting person received 19,255 shares of common stock upon the net exercise of 63,934 stock appreciation rights ("SARS"). The reporting person forfeited 25,743 shares of common stock underlying the SARS in payment of the exercise price and 18,936 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. F8 · derivative.underlying_shares: These SARS were previously reported as covering 31,967 shares at an exercise price of $44.79 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 38,187 | $55.62 | $2,123,960.94 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 10 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,745 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F6 · kind: The reporting person received 38,831 shares of common stock upon the net exercise of 106,034 SARS. The reporting person forfeited 29,016 shares of common stock underlying the SARS in payment of the exercise price and 38,187 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 29,016 | $55.62 | $1,613,869.92 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 9 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,932 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F6 · kind: The reporting person received 38,831 shares of common stock upon the net exercise of 106,034 SARS. The reporting person forfeited 29,016 shares of common stock underlying the SARS in payment of the exercise price and 38,187 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 106,034 | $15.22 | $1,613,837.48 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 8 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F6 · kind: The reporting person received 38,831 shares of common stock upon the net exercise of 106,034 SARS. The reporting person forfeited 29,016 shares of common stock underlying the SARS in payment of the exercise price and 38,187 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 8,574 | $55.62 | $476,885.88 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 7 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,914 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F5 · kind: The reporting person received 8,719 shares of common stock upon the net exercise of 37,528 SARS. The reporting person forfeited 20,235 shares of common stock underlying the SARS in payment of the exercise price and 8,574 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 20,235 | $55.62 | $1,125,470.70 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 6 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,488 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F5 · kind: The reporting person received 8,719 shares of common stock upon the net exercise of 37,528 SARS. The reporting person forfeited 20,235 shares of common stock underlying the SARS in payment of the exercise price and 8,574 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 37,528 | $29.99 | $1,125,464.72 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 5 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F5 · kind: The reporting person received 8,719 shares of common stock upon the net exercise of 37,528 SARS. The reporting person forfeited 20,235 shares of common stock underlying the SARS in payment of the exercise price and 8,574 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 18,936 | $55.62 | $1,053,220.32 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 4 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,195 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F4 · kind: The reporting person received 19,255 shares of common stock upon the net exercise of 63,934 stock appreciation rights ("SARS"). The reporting person forfeited 25,743 shares of common stock underlying the SARS in payment of the exercise price and 18,936 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 25,743 | $55.62 | $1,431,825.66 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 3 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,131 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F4 · kind: The reporting person received 19,255 shares of common stock upon the net exercise of 63,934 stock appreciation rights ("SARS"). The reporting person forfeited 25,743 shares of common stock underlying the SARS in payment of the exercise price and 18,936 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 63,934 | $22.40 | $1,432,121.60 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 2 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F4 · kind: The reporting person received 19,255 shares of common stock upon the net exercise of 63,934 stock appreciation rights ("SARS"). The reporting person forfeited 25,743 shares of common stock underlying the SARS in payment of the exercise price and 18,936 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:33 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 33,070 | $55.64 | $1,840,014.80 |
DisclosureSEC source: 0001209191-18-051478 · doc4.xml · nonDerivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,940 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $55.06 to $56.04. The price reported reflects the weighted average sale price of $55.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 95,505 additional shares of common stock. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 23:39 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 50,000 | $0.00 Strike: $6.82 | $0.00 |
DisclosureSEC source: 0001209191-18-017847 · doc4.xml · derivative · entry 8 PEZZULLO DAVID · CIK 0001311282 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The reporting person received 24,413 shares of common stock upon the net exercise of the 50,000 SARs. The reporting person forfeited 3,618 shares of common stock underlying the SARs in payment of the exercise price and 21,969 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 5, 2018 of $94.27. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.